Ligand validation:5NIW

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5NIW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NIW_NAG_A_606	77%	21%	0.09	0.93	1.2	2.23	1	6	0	0	100%	0.9333
5NIW_NAG_A_608	72%	28%	0.105	0.928	0.96	2.06	-	9	0	0	100%	0.9333
5NIW_NAG_A_609	71%	23%	0.09	0.91	1.47	1.89	2	3	0	0	100%	0.9333
5NIW_NAG_A_610	7%	47%	0.252	0.698	0.67	1.37	-	1	0	0	100%	0.9333
5NIW_NAG_A_607	2%	26%	0.41	0.657	0.77	2.37	1	10	1	1	100%	0.9333
3QVP_NAG_A_603	96%	66%	0.062	0.972	0.48	0.79	-	-	0	0	100%	0.9333
3QVR_NAG_A_605	93%	68%	0.065	0.96	0.53	0.67	-	-	0	0	100%	0.9333
1CF3_NAG_A_605	85%	42%	0.098	0.963	1.3	1	1	1	0	0	100%	0.9333
1GAL_NAG_A_605	79%	23%	0.116	0.961	1.36	1.95	3	4	0	0	100%	0.9333
8JPZ_NAG_B_606	78%	81%	0.117	0.959	0.41	0.41	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.